Ozcan Kara, P <br/><br/>
The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.  [electronic resource] 

 -  Revista espanola de medicina nuclear e imagen molecular  Sep 2012 
 - 257-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>2253-8070 
<br/><br/><label>Standard No.: </label>10.1016/j.remn.2011.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Aged<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>Chemoradiotherapy<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Endometrial Neoplasms--blood<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hysterectomy<br/>Liver Neoplasms--diagnostic imaging<br/>Lymphatic Metastasis--diagnostic imaging<br/>Magnetic Resonance Imaging<br/>Middle Aged<br/>Multimodal Imaging<br/>Neoplasm Staging<br/>Peritoneal Neoplasms--diagnostic imaging<br/>Positron-Emission Tomography<br/>Radiotherapy, Adjuvant<br/>Retrospective Studies<br/>Sensitivity and Specificity<br/>Splenic Neoplasms--diagnostic imaging<br/>Tomography, X-Ray Computed<br/>Ultrasonography